Real-time enrollment status for this hiv (human immunodeficiency virus) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:34 AM UTC
| NCT Number | NCT07217379 |
| Recruiting Status | Recruiting |
| Condition | HIV (Human Immunodeficiency Virus) |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of North Carolina, Chapel Hill |
| Last Updated on CT.gov | December 12, 2025 (Dec 12, 2025) |
As of July 18, 2026: Clinical trial NCT07217379 is currently recruiting participants. This phase1 study for hiv (human immunodeficiency virus) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of North Carolina, Chapel Hill. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07217379 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07217379 was last updated Dec 12, 2025 (December 12, 2025). HelloStudys verifies this status automatically.